IMNM logo

Immunome, Inc. (IMNM) Selling, General & Administrative Expenses

Annual SG&A:

$32.95M+$13.30M(+67.65%)
December 31, 2024

Summary

  • As of today, IMNM annual SG&A is $32.95 million, with the most recent change of +$13.30 million (+67.65%) on December 31, 2024.
  • During the last 3 years, IMNM annual SG&A has risen by +$21.86 million (+197.05%).
  • IMNM annual SG&A is now at all-time high.

Performance

IMNM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMincome statement metrics

Quarterly SG&A:

$10.04M-$648.00K(-6.06%)
June 30, 2025

Summary

  • As of today, IMNM quarterly SG&A is $10.04 million, with the most recent change of -$648.00 thousand (-6.06%) on June 30, 2025.
  • Over the past year, IMNM quarterly SG&A has increased by +$3.06 million (+43.91%).
  • IMNM quarterly SG&A is now -6.06% below its all-time high of $10.69 million, reached on March 31, 2025.

Performance

IMNM Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMincome statement metrics

TTM SG&A:

-$2.11B-$212.39M(-11.20%)
June 30, 2025

Summary

  • As of today, IMNM TTM SG&A is -$2.11 billion, with the most recent change of -$212.39 million (-11.20%) on June 30, 2025.
  • Over the past year, IMNM TTM SG&A has dropped by -$2.13 billion (-8405.80%).
  • IMNM TTM SG&A is now -5670.46% below its all-time high of -$36.56 million.

Performance

IMNM TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

IMNM Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+67.7%+43.9%-8405.8%
3Y3 Years+197.1%+212.9%-10000.0%
5Y5 Years+2061.0%+1120.2%-10000.0%

IMNM Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+197.1%-6.1%+243.7%-458.4%at low
5Y5-Yearat high+2061.0%-6.1%+755.4%-1537.5%at low
All-TimeAll-Timeat high+3705.4%-6.1%+2102.2%-5670.5%at low

IMNM Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$10.04M(-6.1%)
$40.70M(+8.1%)
Mar 2025
-
$10.69M(+2.3%)
$37.64M(+14.2%)
Dec 2024
$32.95M(+67.7%)
$10.45M(+9.7%)
$32.95M(+7.9%)
Sep 2024
-
$9.53M(+36.5%)
$30.55M(+20.3%)
Jun 2024
-
$6.98M(+16.2%)
$25.40M(+11.7%)
Mar 2024
-
$6.00M(-25.3%)
$22.74M(+15.7%)
Dec 2023
$19.66M(+44.2%)
$8.04M(+83.8%)
$19.66M(+29.7%)
Sep 2023
-
$4.38M(+1.3%)
$15.15M(+7.6%)
Jun 2023
-
$4.32M(+47.8%)
$14.09M(+8.6%)
Mar 2023
-
$2.92M(-17.3%)
$12.97M(-4.8%)
Dec 2022
$13.63M
$3.54M(+6.8%)
$13.63M(+0.6%)
Sep 2022
-
$3.31M(+3.1%)
$13.55M(+0.7%)
DateAnnualQuarterlyTTM
Jun 2022
-
$3.21M(-10.3%)
$13.45M(+5.5%)
Mar 2022
-
$3.58M(+3.4%)
$12.75M(+14.9%)
Dec 2021
$11.09M(+132.3%)
$3.46M(+7.8%)
$11.09M(+12.4%)
Sep 2021
-
$3.21M(+28.0%)
$9.87M(+26.0%)
Jun 2021
-
$2.51M(+30.7%)
$7.84M(+27.4%)
Mar 2021
-
$1.92M(-14.3%)
$6.15M(+28.9%)
Dec 2020
$4.78M(+213.1%)
$2.24M(+90.6%)
$4.78M(+59.5%)
Sep 2020
-
$1.17M(+42.6%)
$2.99M(+29.8%)
Jun 2020
-
$823.00K(+52.4%)
$2.31M(+55.5%)
Mar 2020
-
$540.00K(+18.4%)
$1.48M(+57.3%)
Dec 2019
$1.52M(+76.1%)
$456.00K(-6.2%)
$942.00K(+93.8%)
Sep 2019
-
$486.00K
$486.00K
Dec 2018
$866.00K
-
-

FAQ

  • What is Immunome, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Immunome, Inc.?
  • What is Immunome, Inc. annual SG&A year-on-year change?
  • What is Immunome, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Immunome, Inc.?
  • What is Immunome, Inc. quarterly SG&A year-on-year change?
  • What is Immunome, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Immunome, Inc.?
  • What is Immunome, Inc. TTM SG&A year-on-year change?

What is Immunome, Inc. annual SG&A?

The current annual SG&A of IMNM is $32.95M

What is the all-time high annual SG&A for Immunome, Inc.?

Immunome, Inc. all-time high annual SG&A is $32.95M

What is Immunome, Inc. annual SG&A year-on-year change?

Over the past year, IMNM annual SG&A has changed by +$13.30M (+67.65%)

What is Immunome, Inc. quarterly SG&A?

The current quarterly SG&A of IMNM is $10.04M

What is the all-time high quarterly SG&A for Immunome, Inc.?

Immunome, Inc. all-time high quarterly SG&A is $10.69M

What is Immunome, Inc. quarterly SG&A year-on-year change?

Over the past year, IMNM quarterly SG&A has changed by +$3.06M (+43.91%)

What is Immunome, Inc. TTM SG&A?

The current TTM SG&A of IMNM is -$2.11B

What is the all-time high TTM SG&A for Immunome, Inc.?

Immunome, Inc. all-time high TTM SG&A is -$36.56M

What is Immunome, Inc. TTM SG&A year-on-year change?

Over the past year, IMNM TTM SG&A has changed by -$2.13B (-8405.80%)
On this page